Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Restorbio Inc (TORC)

Restorbio Inc (TORC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 83,115
  • Shares Outstanding, K 36,454
  • Annual Sales, $ 0 K
  • Annual Income, $ -82,740 K
  • 60-Month Beta 2.43
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.17
Trade TORC with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.81
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/03/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.16
  • Number of Estimates 1
  • High Estimate -0.16
  • Low Estimate -0.16
  • Prior Year -0.68
  • Growth Rate Est. (year over year) +76.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.88 +21.15%
on 09/04/20
2.46 -7.32%
on 09/15/20
-0.03 (-1.30%)
since 08/14/20
3-Month
1.88 +21.15%
on 09/04/20
3.10 -26.45%
on 07/17/20
+0.10 (+4.59%)
since 06/15/20
52-Week
0.86 +165.12%
on 03/19/20
10.50 -78.29%
on 09/16/19
-7.98 (-77.78%)
since 09/13/19

Most Recent Stories

More News
Adicet Announces Completion of Merger with resTORbio

- Adicet Emerges as a Leading Allogeneic Gamma Delta T Cell Therapy Company Focused on Oncology -

TORC : 15.96 (-3.80%)
resTORbio Provides Corporate Update and Reports Second Quarter 2020 Financial Results

BOSTON, July 30, 2020 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat...

TORC : 15.96 (-3.80%)
resTORbio Announces an Award from the National Institute on Aging to Fund a Pilot Study of RTB101 as COVID-19 Prophylaxis in Older Adults

BOSTON, July 28, 2020 (GLOBE NEWSWIRE) -- resTORbio resTORbio, Inc. (Nasdaq: TORC) today announced the award from the National Institute on Aging to fund a randomized, double-blind, placebo-controlled...

TORC : 15.96 (-3.80%)
ALERT: Halper Sadeh LLP is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - MXIM, INWK, TORC

NEW YORK, NY / ACCESSWIRE / July 18, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the following mergers are fair to shareholders. Halper Sadeh LLP may seek increased...

MXIM : 103.14 (-1.18%)
INWK : 2.99 (unch)
TORC : 15.96 (-3.80%)
Rigrodsky & Long, P.A. Files Class Action Suit Against resTORbio, Inc.

WILMINGTON, Del., July 16, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf...

TORC : 15.96 (-3.80%)
DCOM, TORC, GRUB, and NGHC SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers

WILMINGTON, Del., July 13, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

DCOM : 29.28 (-1.71%)
TORC : 15.96 (-3.80%)
GRUB : 6.72 (+10.71%)
NGHC : 34.18 (+0.09%)
SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLP Continues to Investigate Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - IFF, GRUB, TORC

SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLP Continues to Investigate Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - IFF, GRUB, TORC

IFF : 90.83 (-0.82%)
GRUB : 6.72 (+10.71%)
TORC : 15.96 (-3.80%)
FNJN, TORC, GRUB, and WLTW SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers

WILMINGTON, Del., June 22, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

FNJN : 1.5400 (-0.65%)
TORC : 15.96 (-3.80%)
GRUB : 6.72 (+10.71%)
WLTW : 231.56 (-1.19%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Continues to Investigate Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - WLTW, GRUB, TORC

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Continues to Investigate Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - WLTW, GRUB, TORC

WLTW : 231.56 (-1.19%)
GRUB : 6.72 (+10.71%)
TORC : 15.96 (-3.80%)
Lifshitz Law Firm, P.C. Announces Investigation of resTORbio, Inc. (TORC), Taubman Centers, Inc. (TCO), Willis Towers Watson Public Limited Company (WLTW), and Wright Medical Group N.V. (NASDAQ: WMGI)

NEW YORK, June 07, 2020 (GLOBE NEWSWIRE) --

TORC : 15.96 (-3.80%)
TCO : 42.99 (unch)
WLTW : 231.56 (-1.19%)
WMGI : 29.98 (-2.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

resTORbio, Inc. is a clinical-stage biopharmaceutical company. It focused on the development and commercialization of therapeutics for the treatment of aging-related diseases. The company's program consists of rapamycin complex 1 pathway to treat aging-related diseases and conditions. Its lead product...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 2.57
1st Resistance Point 2.42
Last Price 15.96
1st Support Level 2.17
2nd Support Level 2.07
3rd Support Level N/A

See More

Last Price 15.96
52-Week High 10.50
Fibonacci 61.8% 6.82
Fibonacci 50% 5.68
Fibonacci 38.2% 4.54
52-Week Low 0.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar